NovaBay Pharmaceuticals (NBY) Projected to Post Quarterly Earnings on Tuesday

NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) is projected to issue its quarterly earnings data before the market opens on Tuesday, March 25th. Analysts expect the company to announce earnings of ($0.19) per share and revenue of $2.50 million for the quarter.

NovaBay Pharmaceuticals Price Performance

NovaBay Pharmaceuticals stock opened at $0.65 on Monday. The company has a market cap of $2.73 million, a price-to-earnings ratio of -0.07 and a beta of 2.82. NovaBay Pharmaceuticals has a 52-week low of $0.36 and a 52-week high of $9.08.

About NovaBay Pharmaceuticals

NovaBay Pharmaceuticals, Inc develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health.